SunTrust analyst Tobey Sommer raised his price target on eHealth to $50 and kept his Buy rating while also raising his FY19 EBITDA estimate to $36M from $26M and FY20 view to $56M from $39M. The analyst attributes the change to his "increased assumptions for Medicare member retention and cost-effective online enrollment of Medicare members." Sommer also cites his view that "Medicare annual enrollment period was robust and characterized by carriers competing aggressively to drive enrollment higher", which is a "favorable" backdrop for eHealth stock.

Still expects 2024 GAAP net income ($40M)-($20M) and adjusted EBITDA ($5M)-$20M.